NASDAQ:IDXG

Interpace Diagnostics Group Stock Predictions

Healthcare > Medical - Diagnostics & Research

Buy IDXG

*Your capital is at risk

$1.75

-0.0100 (-0.568%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

IDXG Prediction Chart

IDXG Predictions History

Latest community submissions for IDXG.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jan 6, 2017	$6.46 -90.02%	$6.47	V	99.80%	5
Andrew.Saenz.2141	Jan 6, 2017	$7.58 -88.28%	$6.47	X	82.80%	0
JS Pro	Nov 29, 2016	$0.265 -98.50%	$0.180	V	52.80%	0
Abdu Pro @Abdu.1501	Nov 29, 2016	$0.229 -98.70%	$0.180	V	72.80%	0
JS Pro	Nov 25, 2016	$0.130 -99.54%	$0.280	V	46.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for IDXG with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT INTERPACE DIAGNOSTICS GROUP

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited n...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by